Jones Financial Companies
AKRO

Jones Financial Companies’s Akero Therapeutics AKRO Stock Holding History

Jones Financial Companies’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$2.39K – 4399
2025
Q3 		$2.39K Hold
50
– – ﹤0.01% 3631
2025
Q2 		$2.81K Buy
+50
New +$2.27K ﹤0.01% 3354

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jones Financial Companies's AKRO Position: Q4 2025 in Review

Jones Financial Companies sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 50 shares — an estimated $2.39K sold.

Jones Financial Companies first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $2.81K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Jones Financial Companies reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Jones Financial Companies sold 50 Akero Therapeutics shares in Q4 2025, an estimated $2.39K.
  • Jones Financial Companies first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
  • Jones Financial Companies's Akero Therapeutics position peaked at $2.81K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Jones Financial Companies's 13F filing for Q4 2025, filed 17 Feb 2026.